Home Disparity in post-treatment maternal circulating magnesium sulfate levels between twin and singleton gestation: Is this the missing link between plurality and adverse outcome?
Article
Licensed
Unlicensed Requires Authentication

Disparity in post-treatment maternal circulating magnesium sulfate levels between twin and singleton gestation: Is this the missing link between plurality and adverse outcome?

  • Lilach Marom-Haham EMAIL logo , Shali Mazaki-Tovi , Itamar Zilberman , Anat Kalter , Jigal Haas , Eyal Sivan , Eyal Schiff and Yoav Yinon
Published/Copyright: September 13, 2014

Abstract

Objective: Magnesium sulfate (MgSO4) administered to women at risk for preterm delivery decreases the risk of cerebral palsy in their children. However, the neuroprotective effect of MgSO4 has not been shown in twin gestations. Thus, the aim of this study was to determine the maternal serum levels of magnesium in twin vs. singleton pregnancies following intravenous treatment of MgSO4.

Methods: Case control study including two groups of pregnant women who received intravenous MgSO4: (1) twin gestations (n=83) and (2) singleton pregnancies (n=83). Maternal serum magnesium levels 6 and 24 h after initiation of treatment were determined in both groups.

Results: Maternal serum levels of magnesium were significantly lower among patients with twin gestations compared to those with singleton ones 6 h after initiation of treatment (4.6 vs. 4.8 mg/dL, P=0.003). In addition, the rate of pregnant women who obtained therapeutic levels 6 h after initiation of treatment was significantly lower in twin gestations than in singleton ones (36% vs. 58%, P=0.008). Multiple regression analysis revealed that twin gestations were independently and significantly associated with low maternal serum magnesium levels.

Conclusions: Maternal serum concentrations of magnesium are lower in twin pregnancies than in singleton ones following MgSO4 treatment, which might explain the decreased neuroprotective effect of MgSO4 reported in twin pregnancies.


Corresponding author: Dr. Lilach Marom-Haham, Department of Obstetrics and Gynecology, Sheba Medical Center, Tel-Hashomer 52621, Israel, Tel.: +972 54 6308423, Fax: +972 3 5303168, E-mail:

References

[1] Bain E, Middleton P, Crowther CA. Different magnesium sulphate regimens for neuroprotection of the fetus for women at risk of preterm birth. Cochrane Database Syst Rev. 2012;2:CD009302.Search in Google Scholar

[2] Blondel B, Kogan MD, Alexander GR, Dattani N, Kramer MS, Macfarlane A, et al. The impact of increasing number of multiple births on the rates of preterm birth and low birthweight: an international study. Am J Public Health 2002;92:1323–30.Search in Google Scholar

[3] Brubaker SG, Gyamfi C. Prediction and prevention of spontaneous preterm birth in twin gestations. Semin Perinatol. 2012;36:190–4.Search in Google Scholar

[4] Conde-Agudelo A, Romero R. Antenatal magnesium sulfate for the prevention of cerebral palsy in preterm infants less than 34 weeks’ gestation: a systematic review and metaanalysis. Am J Obstet Gynecol. 2009;200:595–609.Search in Google Scholar

[5] Crowther CA, Hiller JE, Doyle LW, Haslam RR; Australasian Collaborative Trial of Magnesium Sulphate (ACTOMg SO4) Collaborative Group. Effect of magnesium sulfate given for neuroprotection before preterm birth: a randomized controlled trial. J Am Med Assoc. 2003;290:2669–76.Search in Google Scholar

[6] Cuminis SK, Nelson KB, Grether JK, Velie EM. Cerebral palsy in four northern California counties, births 1983 through 1985. J Pediatr. 1993;123:230–7.Search in Google Scholar

[7] Cunningham FG, Leveno KJ, Bloom SL, Hauth JC, Rouse DJ, Spong CY. Pregnancy hypertension: Williams obstetrics, 23rd ed. New York: McGraw-Hill, 2010.Search in Google Scholar

[8] Doyle LW, Crowther CA, Middleton P, Marret S, Rouse D. Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus. Cochrane Database Syst Rev. 2009;21:CD004661.Search in Google Scholar

[9] Elliott JP, Radin TG. Serum magnesium levels during magnesium sulfate tocolysis in high-order multiple gestations. J Reprod Med. 1995;40:450–2.Search in Google Scholar

[10] Fonseca EB, Celik E, Parra M, Singh M, Nicolaides KH. Fetal Medicine Foundation Second Trimester Screening Group. Progesterone and the risk of preterm birth among women with a short cervix. N Engl J Med. 2007;357:462–9.Search in Google Scholar

[11] Hassan SS, Romero R, Vidyadhari D, Fusey S, Baxter JK, Khandelwal M, et al. Vaginal progesterone reduces the rate of preterm birth in women with a sonographic short cervix: a multicenter, randomized, double-blind, placebo-controlled trial. Ultrasound Obstet Gynecol. 2011;38:18–31.Search in Google Scholar

[12] Himpens E, Van den Broek C, Costra A, Calders P, Vanhaesebrouck P. Prevalence, type, distribution, and severity of cerebral palsy in relation to gestational age: a meta-analytic review. Dev Med Child Neurol. 2008;50:334–40.Search in Google Scholar

[13] Kametas NA, McAuliffe F, Krampl E, Chambers J, Nicolaides KH. Maternal cardiac function in twin pregnancy. Obstet Gynecol. 2003;102:806–15.Search in Google Scholar

[14] Kiely JL. What is the population-based risk of preterm birth among twins and other multiples? Clin Obstet Gynecol. 1998;41:3–11.Search in Google Scholar

[15] Marret S, Marpeau L, Follet-Bouhamed C, Cambonie G, Astruc D, et al.; le groupe PREMAG. Effect of magnesium sulphate on mortality and neurologic morbidity of the very-preterm newborn (of less than 33 weeks) with two-year neurological outcome: results of the prospective PREMAG trial. Gynecol Obstet Fertil. 2008;36:278–88.Search in Google Scholar

[16] Mason BA, Standley CA, Whitty JE, Cotton DB. Fetal ionized magnesium levels parallel maternal levels during magnesium sulfate therapy for preeclampsia. Am J Obstet Gynecol 1996;175:213–7.Search in Google Scholar

[17] Meis PJ, Klebanoff M, Thom E, Dombrowski MP, Sibai B, Moawad AH, et al. Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate. N Engl J Med. 2003;348:2379–85.Search in Google Scholar

[18] Mitten R, Pryde P, Lee KS, Besinger R, MacMillan W, Karlman R, et al. 258 Impaired clearance of serum magnesium in the very low birth weight (VLBW, <1500 g) neonate as compared to its mother. Am J Obstet Gynecol. 2001;185:S151.Search in Google Scholar

[19] Norman JE, Mackenzie F, Owen P, Mactier H, Hanretty K, Cooper S, et al. Progesterone for the prevention of preterm birth in twin pregnancy (STOPPIT): a randomised, double-blind, placebo-controlled study and meta-analysis. Lancet 2009;373:2034–40.Search in Google Scholar

[20] Pryde PG, Borg MJ, Mittendorf R, Elin RJ. Cord blood ionized magnesium (iMg) levels exceed maternal levels in both untreated and tocolytic magnesium sulfate treated preterm neonates. Am J Obstet Gynecol. 1999;184:S50.Search in Google Scholar

[21] Rode L, Klein K, Nicolaides KH, Krampl-Bettelheim E, Tabor A; PREDICT Group. Prevention of preterm delivery in twin gestations (PREDICT): a multicenter, randomized, placebo-controlled trial on the effect of vaginal micronized progesterone. Ultrasound Obstet Gynecol. 2011;38:272–80.Search in Google Scholar

[22] Romero R, Nicolaides K, Conde-Agudelo A, Tabor A, O’Brien JM, Cetingoz E, et al. Vaginal progesterone in women with an asymptomatic sonographic short cervix in the midtrimester decreases preterm delivery and neonatal morbidity: a systematic review and metaanalysis of individual patient data. Am J Obstet Gynecol. 2012;206:124.e1–19.Search in Google Scholar

[23] Rouse DJ, Hirtz DG, Thom E, Varner MW, Spong CY, et al; Eunice Kennedy Shriver NICHD Maternal-Fetal Medicine Units Network. A randomized, controlled trial of magnesium sulfate for the prevention of cerebral palsy. N Engl J Med. 2008;359:895–905.Search in Google Scholar

[24] Scher AI, Petterson B, Blair E, Ellenberg JH, Grether JK, Haan E, et al. The risk of mortality or cerebral palsy in twins: a collaborative population-based study. Pediatr Res. 2002;52:671–81.Search in Google Scholar

[25] Vohr BR, Wright LL, Poole WK, McDonald SA. Neurodevelopmental outcomes of extremely low birth weight infants <32 weeks’ gestation between 1993 and 1998. Pediatrics 2005;116:635–43.Search in Google Scholar

The authors stated that there are no conflicts of interest regarding the publication of this article.


Article note

This paper was presented at the 33rd Annual Meeting of the SMFM , February 2013, San Francisco, CA (abstract # 130).


Received: 2014-5-10
Accepted: 2014-8-12
Published Online: 2014-9-13
Published in Print: 2015-9-1

©2015 by De Gruyter

Articles in the same Issue

  1. Frontmatter
  2. Editorial
  3. Risk factors for preterm birth and new approaches to its early diagnosis
  4. Review
  5. Avoiding the prenatal programming effects of glucocorticoids: are there alternative treatments for the induction of antenatal lung maturation?
  6. Original articles – Obstetrics
  7. The association of first trimester bleeding with preterm delivery
  8. Cervical sonoelastography for improving prediction of preterm birth compared with cervical length measurement and fetal fibronectin test
  9. The neuroprotective effect of magnesium sulfate in preterm fetal mice
  10. Correlation of cervical length, fetal fibronectin, phIGFBP-1, and cytokines in spontaneous preterm birth up to 14 days from sampling
  11. The unborn smoker: association between smoking during pregnancy and adverse perinatal outcomes
  12. Association of group B streptococcus colonization with early term births
  13. Association of maternal whole blood fatty acid status during the prenatal period with term birth dimensions: a cross-sectional study
  14. Predicting onset of labor from echogenicity of the cervical gland area on vaginal ultrasonography at term
  15. Disparity in post-treatment maternal circulating magnesium sulfate levels between twin and singleton gestation: Is this the missing link between plurality and adverse outcome?
  16. Original articles – Fetus
  17. Cardiovascular profile score in 44 fetuses with cervicofacial tumors
  18. First trimester tricuspid regurgitation and fetal abnormalities
  19. Gastroschisis: incidence and prediction of growth restriction
  20. Original articles – Newborn
  21. Diminished HLA-DR expression on monocyte and dendritic cell subsets indicating impairment of cellular immunity in pre-term neonates: a prospective observational analysis
  22. First- and fifth-minute Apgar scores of 0–3 and infant mortality: a population-based study in São Paulo State of Brazil
  23. Feeding the feeble: steps towards nourishing preterm infants
  24. Book review
  25. Hot topics in perinatal medicine
  26. Erratum
  27. Erratum to: Impact of the nitric oxide-donor pentaerythrityl-tetranitrate on perinatal outcome in risk pregnancies: a prospective, randomized, double-blinded trial
  28. Congress Calendar
  29. Congress Calendar
Downloaded on 26.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/jpm-2014-0158/html
Scroll to top button